Related references
Note: Only part of the references are listed.Tumour targeting with radiometals for diagnosis and therapy
Caterina F. Ramogida et al.
CHEMICAL COMMUNICATIONS (2013)
Radiosynthesis of [18F]FEt-Tyr-urea-Glu ([18F]FEtTUG) as a new PSMA ligand
E. Al-Momani et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2013)
One pot radiofluorination of a new potential PSMA ligand [Al18F]NOTA-DUPA-Pep
Noeen Malik et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2012)
A cell permeable peptide analog as a potential-specific PET imaging probe for prostate cancer detection
Guiyang Hao et al.
AMINO ACIDS (2011)
Radiosynthesis of a new PSMA targeting ligand ([18F]FPy-DUPA-Pep)
Noeen Malik et al.
APPLIED RADIATION AND ISOTOPES (2011)
2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
Ying Chen et al.
CLINICAL CANCER RESEARCH (2011)
A Universally Applicable 68Ga-Labeling Technique for Proteins
Carmen Waengler et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
Thaddeus J. Wadas et al.
CHEMICAL REVIEWS (2010)
p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging
Lars R. Perk et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Synthesis and Biological Analysis of Prostate-Specific Membrane Antigen-Targeted Anticancer Prodrugs
Sumith A. Kularatne et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Prostate-Specific Membrane Antigen Targeted Imaging and Therapy of Prostate Cancer Using a PSMA Inhibitor as a Homing Ligand
Sumith A. Kularatne et al.
MOLECULAR PHARMACEUTICS (2009)
Standardized methods for the production of high specific-activity zirconium-89
Jason P. Holland et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Clinical Trials of Cancer Therapies Targeting Prostate-Specific Membrane Antigen
William C. Olson et al.
REVIEWS ON RECENT CLINICAL TRIALS (2007)
Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen
DS Ma et al.
CLINICAL CANCER RESEARCH (2006)
Radiolabeled small-molecule ligands for prostate-specific membrane antigen:: In vivo imaging in experimental models of prostate cancer
CA Foss et al.
CLINICAL CANCER RESEARCH (2005)
68Ga-labelled DOTA-derivatised peptide ligands
GJ Meyer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Share Paper
